G. Bulaj

发表

Erratum: Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature (Natural Product Reports (2013) 30 (108-160) DOI:10.1039/C2NP20085F)

P. G. Arnison, M. Bibb, B. Shen, 2013 .

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.

P. G. Arnison, M. Bibb, B. Shen, 2013, Natural product reports.

Ionization-reactivity relationships for cysteine thiols in polypeptides.

T. Kortemme, D. Goldenberg, D. Goldenberg, 1998, Biochemistry.

Propeptide does not act as an intramolecular chaperone but facilitates protein disulfide isomerase-assisted folding of a conotoxin precursor.

G. Bulaj, B. Olivera, O. Buczek, 2004, Biochemistry.

Conus venoms - a rich source of peptide-based therapeutics.

G. Bulaj, B. Olivera, Russell W. Teichert, 2008, Current pharmaceutical design.

Synthesis and applications of polyamine amino acid residues: improving the bioactivity of an analgesic neuropeptide, neurotensin.

G. Bulaj, H. White, Liuyin Zhang, 2009, Journal of medicinal chemistry.

Cyclic analogs of galanin and neuropeptide Y by hydrocarbon stapling.

G. Bulaj, Misty D. Smith, B. Klein, 2013, Bioorganic & medicinal chemistry.

Introduction of lipidization–cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activities

E. Scholl, G. Bulaj, H. White, 2010, Journal of peptide science : an official publication of the European Peptide Society.

Novel Conantokins from Conus parius Venom Are Specific Antagonists of N-Methyl-D-aspartate Receptors*

M. Hollmann, G. Bulaj, B. Olivera, 2007, Journal of Biological Chemistry.

Combining Non-Pharmacological Treatments with Pharmacotherapies for Neurological Disorders: A Unique Interface of the Brain, Drug–Device, and Intellectual Property

G. Bulaj, 2014, Front. Neurol..

Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases

G. Bulaj, Yizhe Chen, Margaret M. Ahern, 2016, Current clinical pharmacology.

Co‐expression of NaVβ subunits alters the kinetics of inhibition of voltage‐gated sodium channels by pore‐blocking μ‐conotoxins

D. Yoshikami, J. Rivier, G. Bulaj, 2013, British journal of pharmacology.

A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties

R. Baron, J. McIntosh, G. Bulaj, 2015, Front. Pharmacol..

circular permutation Alteration of the disulfide-coupled folding pathway of BPTI by References

D. Goldenberg, G. Bulaj, Rachel E. Koehn, 2004 .

Incorporation of monodisperse oligoethyleneglycol amino acids into anticonvulsant analogues of galanin and neuropeptide y provides peripherally acting analgesics.

G. Bulaj, H. White, Misty D. Smith, 2013, Molecular pharmaceutics.

Reagentless oxidative folding of disulfide-rich peptides catalyzed by an intramolecular diselenide.

A. Steiner, K. J. Woycechowsky, G. Bulaj, 2012, Angewandte Chemie.

Cosolvent‐assisted oxidative folding of a bicyclic α‐conotoxin ImI

G. Bulaj, P. Buczek, J. S. Nielsen, 2004 .

Role of hydroxyprolines in the in vitro oxidative folding and biological activity of conotoxins.

G. Bulaj, B. Olivera, J. Skalicky, 2008, Biochemistry.

Patient-Empowerment Interactive Technologies

Craig B Caldwell, Julie R Korenberg, J. Korenberg, 2012, Science Translational Medicine.

Structure/Function Characterization of μ-Conotoxin KIIIA, an Analgesic, Nearly Irreversible Blocker of Mammalian Neuronal Sodium Channels*

Brian J. Smith, D. Yoshikami, R. Norton, 2007, Journal of Biological Chemistry.

Selective Purification of Recombinant Neuroactive Peptides Using the Flagellar Type III Secretion System

D. Yoshikami, A. Steiner, K. Hughes, 2012, mBio.

Mu-conotoxin SmIIIA, a potent inhibitor of tetrodotoxin-resistant sodium channels in amphibian sympathetic and sensory neurons.

D. Yoshikami, G. Bulaj, B. Olivera, 2002, Biochemistry.

Efficient oxidative folding of conotoxins and the radiation of venomous cone snails

G. Bulaj, B. Olivera, O. Buczek, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Albumin is a redox-active crowding agent that promotes oxidative folding of cysteine-rich peptides.

G. Bulaj, O. Buczek, B. R. Green, 2007, Biopolymers.

Composition and therapeutic utility of conotoxins from genus Conus. Patent status 1996 - 2000

J. McIntosh, G. Bulaj, B. Olivera, 2001 .

Structure, dynamics and selectivity of the sodium channel blocker µ-conotoxin SIIIA†,,‡

D. Yoshikami, R. Norton, S. Yao, 2014 .

Structural Basis for Tetrodotoxin-resistant Sodium Channel Binding by μ-Conotoxin SmIIIA*

Erinna F. Lee, D. Yoshikami, R. Norton, 2003, Journal of Biological Chemistry.

Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.

E. Scholl, G. Bulaj, H. White, 2008, Journal of medicinal chemistry.

Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues.

G. Bulaj, H. White, Liuyin Zhang, 2009, Journal of medicinal chemistry.

Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.

E. Scholl, G. Bulaj, H. White, 2010, Journal of medicinal chemistry.

Stapling Mimics Noncovalent Interactions of γ-Carboxyglutamates in Conantokins, Peptidic Antagonists of N-Methyl-d-Aspartic Acid Receptors*

Randall J. Platt, G. Bulaj, B. Olivera, 2012, The Journal of Biological Chemistry.

Circular logic: nonribosomal peptide-like macrocyclization with a ribosomal peptide catalyst.

S. Nair, V. Agarwal, G. Bulaj, 2010, Journal of the American Chemical Society.

Commentary: A Breathing-Based Meditation Intervention for Patients with Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study

Skye A McKennon, G. Bulaj, S. E. Levitt, 2017, Frontiers in medicine.

Conantokins Derived from the Asprella Clade Impart Con Rl -B, an NMDA Receptor Antagonist with a Unique Selectivity Profile for NR2B Subunits

Randall J. Platt, G. Bulaj, H. White, 2014 .

Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits.

Randall J. Platt, G. Bulaj, B. Olivera, 2012, Biochemistry.

Disulfide-Depleted Selenoconopeptides: Simplified Oxidative Folding of Cysteine-Rich Peptides

D. Yoshikami, G. Bulaj, B. Olivera, 2010 .

Structurally Minimized μ‐Conotoxin Analogues as Sodium Channel Blockers: Implications for Designing Conopeptide‐Based Therapeutics

T. Cheatham, D. Yoshikami, G. Bulaj, 2009, ChemMedChem.

Integrated oxidative folding of cysteine/selenocysteine containing peptides: improving chemical synthesis of conotoxins.

D. Yoshikami, G. Bulaj, B. Olivera, 2009, Angewandte Chemie.

A disulfide tether stabilizes the block of sodium channels by the conotoxin μO§-GVIIJ

B. Ueberheide, D. Yoshikami, H. M. Zhou, 2014, Proceedings of the National Academy of Sciences.

μ-conotoxin KIIIA derivatives with divergent affinities versus efficacies in blocking voltage-gated sodium channels.

D. Yoshikami, G. Bulaj, B. Olivera, 2010, Biochemistry.

Conantokin-P, an unusual conantokin with a long disulfide loop.

G. Bulaj, B. Olivera, Russell W. Teichert, 2008, Toxicon : official journal of the International Society on Toxinology.

Specificity, affinity and efficacy of iota-conotoxin RXIA, an agonist of voltage-gated sodium channels Na(V)1.2, 1.6 and 1.7.

D. Yoshikami, R. Norton, G. Bulaj, 2008, Biochemical pharmacology.

Characterization of a novel ψ-conotoxin from Conus parius Reeve

G. Bulaj, B. Olivera, M. Watkins, 2008 .

Conotoxins containing nonnatural backbone spacers: cladistic-based design, chemical synthesis, and improved analgesic activity.

Brian J. Smith, D. Yoshikami, R. Norton, 2007, Chemistry & biology.

The μO‐conotoxin MrVIA inhibits voltage‐gated sodium channels by associating with domain‐3

S. Heinemann, E. Leipold, G. Bulaj, 2006, FEBS letters.

Effects of δ-Conotoxins PVIA and SVIE on Sodium Channels in the Amphibian Sympathetic Nervous System

D. Yoshikami, G. Bulaj, P. West, 2005 .

Postischemic Administration of CGX-1051, a Peptide from Cone Snail Venom, Reduces Infarct Size in Both Rat and Dog Models of Myocardial Ischemia and Reperfusion

G. Gross, G. Bulaj, R. Layer, 2005, Journal of cardiovascular pharmacology.

Biochemical and gene expression analyses of conotoxins in Conus textile venom ducts.

G. Bulaj, B. Olivera, O. Buczek, 2005, Biochemical and biophysical research communications.

Total chemical synthesis and oxidative folding of δ‐conotoxin PVIA containing an N‐terminal propeptide

G. Bulaj, O. Buczek, P. Buczek, 2005, Biopolymers.

αA-Conotoxin OIVA defines a new αA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors

J. Rivier, G. Bulaj, B. Olivera, 2004 .

Conorfamide, a Conus venom peptide belonging to the RFamide family of neuropeptides.

G. Bulaj, B. Olivera, M. Aguilar, 2002, Toxicon : official journal of the International Society on Toxinology.

δ-Conotoxin Structure/Function through a Cladistic Analysis†

D. Yoshikami, A. Azimi-Zonooz, G. Bulaj, 2001 .

Oxidative folding of conotoxins in immobilized systems.

G. Bulaj, B. R. Green, 2006, Protein and peptide letters.

Integrating the discovery pipeline for novel compounds targeting ion channels.

G. Bulaj, 2008, Current opinion in chemical biology.

Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels.

Brian J. Smith, D. Yoshikami, R. Norton, 2005, Biochemistry.

Conotoxins and the posttranslational modification of secreted gene products

G. Bulaj, B. Olivera, O. Buczek, 2005, Cellular and Molecular Life Sciences CMLS.

Post-translational Amino Acid Isomerization

D. Yoshikami, G. Bulaj, B. Olivera, 2005, Journal of Biological Chemistry.

Conus peptides - combinatorial chemistry at a cone snail's pace.

G. Bulaj, R. Jones, 2000, Current opinion in drug discovery & development.

Expanding chemical diversity of conotoxins: peptoid-peptide chimeras of the sodium channel blocker μ-KIIIA and its selenopeptide analogues.

D. Yoshikami, G. Bulaj, Min-min Zhang, 2013, European journal of medicinal chemistry.

Unexpected synergism between Tetrodotoxin and μ-conotoxin in blocking voltage-gated sodium channels

M. Zhang, D. Yoshikami, R. French, 2009 .

Synthetic muO-conotoxin MrVIB blocks TTX-resistant sodium channel NaV1.8 and has a long-lasting analgesic activity.

D. Yoshikami, T. Harty, G. Bulaj, 2006, Biochemistry.

Structural and functional diversities among mu-conotoxins targeting TTX-resistant sodium channels.

Brian J. Smith, D. Yoshikami, G. Bulaj, 2006, Biochemistry.

Disulfide-Depleted Selenoconopeptides: a Minimalist Strategy to Oxidative Folding of Cysteine-Rich Peptides.

D. Yoshikami, G. Bulaj, B. Olivera, 2010, ACS medicinal chemistry letters.

STRUCTURE/FUNCTION CHARACTERIZATION OF μ -CONOTOXIN KIIIA, AN ANALGESIC, NEARLY IRREVERSIBLE BLOCKER OF NEURONAL MAMMALIAN SODIUM CHANNELS*

D. Yoshikami, R. Norton, J. Rivier, 2007 .

Interactions of disulfide‐deficient selenocysteine analogs of μ‐conotoxin BuIIIB with the α‐subunit of the voltage‐gated sodium channel subtype 1.3

D. Yoshikami, R. Norton, S. Robinson, 2014, The FEBS journal.

Generating Orally Active Galanin Analogues with Analgesic Activities

G. Bulaj, H. White, Timothy H. Pruess, 2012, ChemMedChem.

Structure, dynamics, and selectivity of the sodium channel blocker mu-conotoxin SIIIA.

D. Yoshikami, R. Norton, S. Yao, 2008, Biochemistry.

Improving Fmoc Solid Phase Synthesis of Human Beta Defensin 3

G. Bulaj, A. Prahl, Aleksandra Walewska, 2022, International journal of molecular sciences.

Probing the Redox States of Sodium Channel Cysteines at the Binding Site of μO§-Conotoxin GVIIJ.

D. Yoshikami, G. Bulaj, B. Olivera, 2015, Biochemistry.

Isolation and Characterization of a Novel ConusPeptide with Apparent Antinociceptive Activity*

D. Yoshikami, J. McIntosh, G. Bulaj, 2000, The Journal of Biological Chemistry.

Glycosylated Neurotensin Analogues Exhibit Sub‐picomolar Anticonvulsant Potency in a Pharmacoresistant Model of Epilepsy

G. Bulaj, H. White, Liuyin Zhang, 2009, ChemMedChem.

Characterization of conantokin Rl‐A: molecular phylogeny as structure/function study

G. Bulaj, B. Olivera, M. Watkins, 2010, Journal of peptide science : an official publication of the European Peptide Society.

Analgesic Properties of a Peripherally Acting and GalR2 Receptor–Preferring Galanin Analog in Inflammatory, Neuropathic, and Acute Pain Models

G. Bulaj, H. White, Liuyin Zhang, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Synergistic effects of the galanin analog 810–2 with the antiseizure medication levetiracetam in rodent seizure models

G. Bulaj, H. White, Cameron S. Metcalf, 2022, Epilepsia.

Analgesic neuropeptide W suppresses seizures in the brain revealed by rational repositioning and peptide engineering.

G. Bulaj, H. White, B. R. Green, 2011, ACS chemical neuroscience.

The Cys-Xaa-His metal-binding motif: {N} versus {S} coordination and nickel-mediated formation of cysteinyl sulfinic acid

D. Goldenberg, G. Bulaj, C. Burrows, 2003, JBIC Journal of Biological Inorganic Chemistry.

Dissecting a role of evolutionary‐conserved but noncritical disulfide bridges in cysteine‐rich peptides using ω‐conotoxin GVIA and its selenocysteine analogs

A. Steiner, G. Bulaj, B. Olivera, 2012, Biopolymers.

Optimization of oxidative folding methods for cysteine‐rich peptides: a study of conotoxins containing three disulfide bridges

A. Steiner, G. Bulaj, 2011, Journal of peptide science : an official publication of the European Peptide Society.

Converting peptides into drug leads by lipidation.

G. Bulaj, L. Zhang, 2012, Current medicinal chemistry.

Formation of disulfide bonds in proteins and peptides.

G. Bulaj, 2005, Biotechnology advances.

Anticonvulsant neuropeptides as drug leads for neurological diseases.

G. Bulaj, H. White, S. Flynn, 2011, Natural product reports.

Single peptide bond hydrolysis/resynthesis in squash inhibitors of serine proteinases. 2. Limited proteolysis of Curcurbita maxima trypsin inhibitor I by pepsin.

J. Otlewski, T. Wilusz, G. Bulaj, 1994, Biochemistry.

Effect of acrylamide on aldolase structure. I. Induction of intermediate states.

G. Bulaj, M. Kochman, P. Dobryszycki, 1999, Biochimica et biophysica acta.

Pharmacological fractionation of tetrodotoxin‐sensitive sodium currents in rat dorsal root ganglion neurons by μ‐conotoxins

D. Yoshikami, J. Rivier, G. Bulaj, 2013, British journal of pharmacology.

Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity.

R. Norton, G. Bulaj, B. R. Green, 2014, Future medicinal chemistry.

μ-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve

D. Yoshikami, G. Bulaj, B. Olivera, 2011, Proceedings of the National Academy of Sciences.

Pruning nature: Biodiversity-derived discovery of novel sodium channel blocking conotoxins from Conus bullatus.

D. Yoshikami, G. Bulaj, B. Olivera, 2009, Toxicon : official journal of the International Society on Toxinology.

Characterization of a novel psi-conotoxin from Conus parius Reeve.

G. Bulaj, B. Olivera, M. Watkins, 2008, Toxicon : official journal of the International Society on Toxinology.

Characterization of D‐amino‐acid‐containing excitatory conotoxins and redefinition of the I‐conotoxin superfamily

D. Yoshikami, G. Bulaj, B. Olivera, 2005, The FEBS journal.

Structure and sodium channel activity of an excitatory I1-superfamily conotoxin.

D. Yoshikami, R. Norton, Daxiu Wei, 2007, Biochemistry.

Mammalian neuronal sodium channel blocker μ-conotoxin BuIIIB has a structured N-terminus that influences potency.

D. Yoshikami, R. Norton, P. Balaram, 2013, ACS chemical biology.

Cooccupancy of the outer vestibule of voltage-gated sodium channels by micro-conotoxin KIIIA and saxitoxin or tetrodotoxin.

D. Yoshikami, G. Bulaj, B. Olivera, 2010, Journal of neurophysiology.

Distinct disulfide isomers of μ-conotoxins KIIIA and KIIIB block voltage-gated sodium channels.

D. Yoshikami, R. Norton, P. Balaram, 2012, Biochemistry.

Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion.

Brian J. Smith, D. Yoshikami, R. Norton, 2009, Biochemistry.

Alteration of the disulfide‐coupled folding pathway of BPTI by circular permutation

D. Goldenberg, G. Bulaj, David P Goldenberg, 2004, Protein science : a publication of the Protein Society.

Mutational analysis of hydrogen bonding residues in the BPTI folding pathway.

D. Goldenberg, G. Bulaj, David M. Goldenberg, 2001, Journal of molecular biology.

φ-Values for BPTI folding intermediates and implications for transition state analysis

D. Goldenberg, G. Bulaj, 2001, Nature Structural Biology.

Early events in the disulfide‐coupled folding of BPTI

D. Goldenberg, G. Bulaj, 1999, Protein science : a publication of the Protein Society.

The novel anticonvulsant neuropeptide and galanin analogue, NAX‐5055, does not alter energy and amino acid metabolism in cultured brain cells

A. Schousboe, G. Bulaj, H. Waagepetersen, 2017, Journal of neuroscience research.

Music-Enhanced Analgesia and Antiseizure Activities in Animal Models of Pain and Epilepsy: Toward Preclinical Studies Supporting Development of Digital Therapeutics and Their Combinations With Pharmaceutical Drugs

G. Bulaj, A. Kochanski, H. White, 2019, Front. Neurol..

Mobile Software as a Medical Device (SaMD) for the Treatment of Epilepsy: Development of Digital Therapeutics Comprising Behavioral and Music-Based Interventions for Neurological Disorders

Matthew T. Sweney, P. Afra, G. Bulaj, 2018, Front. Hum. Neurosci..

From molecular phylogeny towards differentiating pharmacology for NMDA receptor subtypes.

Randall J. Platt, G. Bulaj, B. Olivera, 2014, Toxicon : official journal of the International Society on Toxinology.

Identification of Conus Peptidylprolyl Cis-Trans Isomerases (PPIases) and Assessment of Their Role in the Oxidative Folding of Conotoxins

A. Purcell, G. Bulaj, B. Olivera, 2010, The Journal of Biological Chemistry.

Improving Self-Esteem With Motivational Quotes: Opportunities for Digital Health Technologies for People With Chronic Disorders

G. Bulaj, Alisa Bedrov, 2018, Front. Psychol..

NaVβ Subunits Modulate the Inhibition of NaV1.8 by the Analgesic Gating Modifier μO-Conotoxin MrVIB

D. Yoshikami, G. Bulaj, B. Olivera, 2011, Journal of Pharmacology and Experimental Therapeutics.

Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads.

G. Bulaj, B. Olivera, Grzegorz Bulaj, 2009, Current opinion in drug discovery & development.

NMR-based mapping of disulfide bridges in cysteine-rich peptides: application to the mu-conotoxin SxIIIA.

D. Yoshikami, G. Bulaj, B. Olivera, 2008, Journal of the American Chemical Society.

Oxidative folding of conotoxins sharing an identical disulfide bridging framework

G. Bulaj, B. Olivera, O. Buczek, 2005, The FEBS journal.

Ligand-induced changes in the conformational stability of bovine trypsinogen and their implications for the protein function.

J. Otlewski, G. Bulaj, 1995, Journal of molecular biology.

Denaturation of free and complexed bovine trypsinogen with the calcium ion, dipeptide Ile-Val and basic pancreatic trypsin inhibitor (Kunitz).

J. Otlewski, G. Bulaj, 1994, European journal of biochemistry.

Lactam-stabilized helical analogues of the analgesic μ-conotoxin KIIIA.

Brian J. Smith, D. Yoshikami, R. Norton, 2011, Journal of medicinal chemistry.

Anticonvulsant Met-enkephalin analogues containing backbone spacers reveal alternative non-opioid signaling in the brain.

Brian J. Smith, R. Gillies, G. Bulaj, 2009, ACS Chemical Biology.

Selenopeptide Analogs of EETI‐II Retain Potent Trypsin Inhibitory Activities

A. Jaśkiewicz, G. Bulaj, K. Rolka, 2011, Chemical biology & drug design.

Detergent-assisted oxidative folding of delta-conotoxins.

G. Bulaj, F. Whitby, O. Buczek, 2003, The journal of peptide research : official journal of the American Peptide Society.

From Precision Metapharmacology to Patient Empowerment: Delivery of Self-Care Practices for Epilepsy, Pain, Depression and Cancer Using Digital Health Technologies

M. Ebrahimi, G. Bulaj, Jacqueline Clark, 2021, Frontiers in Pharmacology.

Preclinical evaluation of intravenous NAX 810‐2, a novel GalR2‐preferring analog, for anticonvulsant efficacy and pharmacokinetics

G. Bulaj, H. White, Liuyin Zhang, 2017, Epilepsia.

Detergent-assisted oxidative folding of -conotoxins: Assisted folding of conotoxins

G. Bulaj, F. Whitby, O. Buczek, 2008 .

Folding of conotoxins: formation of the native disulfide bridges during chemical synthesis and biosynthesis of Conus peptides.

G. Bulaj, B. Olivera, 2008, Antioxidants & redox signaling.

Clinical and Neurobiological Perspectives of Empowering Pediatric Cancer Patients Using Videogames

G. Bulaj, Grzegorz Bulaj, Meveshni Govender, 2015, Games for health journal.

Developing novel antiepileptic drugs: Characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models

E. Scholl, G. Bulaj, H. White, 2009, Neurotherapeutics.

CHAPTER 6:The Molecular Diversity of Conoidean Venom Peptides and their Targets: From Basic Research to Therapeutic Applications

J. McIntosh, G. Bulaj, B. Olivera, 2015 .

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2

G. Bulaj, Liuyin Zhang, Cameron S. Metcalf, 2017, Neurochemical Research.

Music Streaming Services as Adjunct Therapies for Depression, Anxiety, and Bipolar Symptoms: Convergence of Digital Technologies, Mobile Apps, Emotions, and Global Mental Health

G. Bulaj, Grzegorz Bulaj, Karl Schriewer, 2016, Front. Public Health.

Structure of a Novel P-superfamily Spasmodic Conotoxin Reveals an Inhibitory Cystine Knot Motif* 210

R. Norton, M. Hinds, G. Bulaj, 2002, The Journal of Biological Chemistry.

Modulation of Conotoxin Structure and Function Is Achieved through a Multienzyme Complex in the Venom Glands of Cone Snails*

A. Steiner, A. Purcell, G. Bulaj, 2012, The Journal of Biological Chemistry.

esized and post-translationally modi fi ed peptide natural products : overview and recommendations for a universal nomenclature

P. G. Arnison, M. Bibb, M. Fischbach, 2012 .

Site-specific effects of diselenide bridges on the oxidative folding of a cystine knot peptide, omega-selenoconotoxin GVIA.

G. Bulaj, B. Olivera, J. Skalicky, 2010, Biochemistry.

On the Importance of Oxidative Folding in the Evolution of Conotoxins: Cysteine Codon Preservation through Gene Duplication and Adaptation

A. Steiner, N. Puillandre, G. Bulaj, 2013, PloS one.

The anticonvulsant action of the galanin receptor agonist NAX-5055 involves modulation of both excitatory- and inhibitory neurotransmission

A. Schousboe, G. Bulaj, L. K. Bak, 2016, Epilepsy Research.

A Prototype Exercise–Empowerment Mobile Video Game for Children With Cancer, and Its Usability Assessment: Developing Digital Empowerment Interventions for Pediatric Diseases

G. Bulaj, Grzegorz Bulaj, Carol S. Bruggers, 2018, Front. Pediatr..

Structural Basis for the Inhibition of Voltage-gated Sodium Channels by Conotoxin μO§-GVIIJ*

D. Yoshikami, R. Norton, J. Rivier, 2015, The Journal of Biological Chemistry.

The intersection of video games and patient empowerment: case study of a real world application

Roger Altizer, Craig Caldwell, Robert Kessler, 2013, IE.

Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor.

R. Kazmierkiewicz, G. Bulaj, B. Olivera, 2009, Biochemistry.

Structure of conkunitzin-S1, a neurotoxin and Kunitz-fold disulfide variant from cone snail

G. Bulaj, J. Imperial, M. Horvath, 2006, Acta crystallographica. Section D, Biological crystallography.

Developing music streaming as an adjunct digital therapy for depression: A survey study to assess support from key stakeholders

C. Tak, G. Bulaj, Shannon Gadd, 2020 .

Pharmacological fractionation of tetrodotoxin‐sensitive sodium currents in rat dorsal root ganglion neurons by μ‐conotoxins

D. Yoshikami, J. Rivier, G. Bulaj, 2013, British journal of pharmacology.

Anticonvulsant neuropeptides as drug leads for neurological diseases.

G. Bulaj, S. Flynn, C. Robertson, 2011, Natural product reports.

NaVβ Subunits Modulate the Inhibition of NaV1.8 by the Analgesic Gating Modifier μO-Conotoxin MrVIB

D. Yoshikami, G. Bulaj, B. Olivera, 2011, Journal of Pharmacology and Experimental Therapeutics.

Pruning nature: Biodiversity-derived discovery of novel sodium channel blocking conotoxins from Conus bullatus.

D. Yoshikami, G. Bulaj, B. Olivera, 2009, Toxicon : official journal of the International Society on Toxinology.

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.

M. Bibb, B. Shen, M. Fischbach, 2013, Natural product reports.

Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity.

R. Norton, G. Bulaj, B. R. Green, 2014, Future medicinal chemistry.

μ-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve

D. Yoshikami, G. Bulaj, B. Olivera, 2011, Proceedings of the National Academy of Sciences.

Integrating the discovery pipeline for novel compounds targeting ion channels.

G. Bulaj, 2008, Current opinion in chemical biology.

Patient-Empowerm ent Technologies

G. Bulaj, R. Kessler, 2016 .